Analyzing Generation Alpha (OTCMKTS:GNAL) & Flora Growth (NASDAQ:FLGC)

Generation Alpha (OTCMKTS:GNAL) and Flora Growth (NASDAQ:FLGC) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Valuation & Earnings

This table compares Generation Alpha and Flora Growth”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Generation Alpha	N/A	N/A	N/A	N/A	N/A
Flora Growth	$57.61 million	0.07	-$15.91 million	($32.49)	-0.12

Generation Alpha has higher earnings, but lower revenue than Flora Growth.

Risk and Volatility

Generation Alpha has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.9, meaning that its share price is 90% more volatile than the S&P 500.

Profitability

This table compares Generation Alpha and Flora Growth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Generation Alpha	N/A	N/A	N/A
Flora Growth	-32.03%	-64.02%	-34.46%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Generation Alpha and Flora Growth, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Generation Alpha	0	0	0	0	0.00
Flora Growth	1	0	1	0	2.00

Flora Growth has a consensus price target of $30.00, suggesting a potential upside of 642.57%. Given Flora Growth’s stronger consensus rating and higher probable upside, analysts plainly believe Flora Growth is more favorable than Generation Alpha.

Institutional and Insider Ownership

36.0% of Flora Growth shares are owned by institutional investors. 60.8% of Generation Alpha shares are owned by company insiders. Comparatively, 2.3% of Flora Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Flora Growth beats Generation Alpha on 6 of the 10 factors compared between the two stocks.

About Generation Alpha

Generation Alpha, Inc. focuses on the research, design, development, and manufacturing of indoor horticulture lighting, plant nutrient products, and ancillary equipment in the United States and internationally. The company offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produce less heat; digital lighting controller, a temperature monitoring control system; reflectors; and high intensity lighting accessories, as well as plant nutrients and fertilizers. It primarily serves commercial and retail cannabis growers in the medical and adult use recreational markets; distributors; and retailers. Generation Alpha, Inc. markets its products directly; and through distributors to hydroponic retailers, as well as through direct contacts, online email advertising, social media, trade magazine advertising, trade show promotions, and cross-promotional offerings, as well as ecommerce websites. The company was formerly known as Solis Tek Inc. Generation Alpha, Inc. was incorporated in 2007 and is based in Upland, California.

About Flora Growth

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.